Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Leukemia 33Breast Neoplasms 20Leukemia, Myeloid, Acute 15Carcinoma, Non-Small-Cell Lung 14Lung Neoplasms 13Head and Neck Neoplasms 13Congenital Abnormalities 12Squamous Cell Carcinoma of Head and Neck 10Precursor Cell Lymphoblastic Leukemia-Lymphoma 9Lymphoma 9Kidney Neoplasms 9Central Nervous System Neoplasms 9Sarcoma 8Rectal Neoplasms 8Leukemia, Megakaryoblastic, Acute 8Colorectal Neoplasms 8Colonic Neoplasms 8Lymphoma, Follicular 7Leukemia, Myelomonocytic, Acute 7Leukemia, Monocytic, Acute 7Leukemia, Erythroblastic, Acute 7Gliosarcoma 7Glioblastoma 7Multiple Myeloma 6Melanoma 6Neuroblastoma 5Lymphoma, Large B-Cell, Diffuse 5Esophageal Neoplasms 5Carcinoma, Intraductal, Noninfiltrating 5Wilms Tumor 4

Interventions

Gemcitabine 74Capecitabine 60Paclitaxel 59Fluorouracil 58Oxaliplatin 57Bevacizumab 51Docetaxel 50Leucovorin 48Nivolumab 40Cisplatin 40Irinotecan 39Carboplatin 37Cetuximab 34pembrolizumab 32Radiosurgery 32Trastuzumab 30Radiotherapy 27Everolimus 24Sorafenib 23Pemetrexed 20Doxorubicin 20Albumin-Bound Paclitaxel 20Ipilimumab 19Cyclophosphamide 19Panitumumab 18Zoledronic Acid 17Lapatinib 17Erlotinib Hydrochloride 17Prednisone 16pazopanib 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Neoplasm Metastasis × Gene Expression Profiling × Clear all
NCT00544804 2014-07-02

Lapatinib in Treating Patients With Advanced or Metastatic Breast Cancer That Overexpresses HER2

University of California, San Francisco

Phase 1 Completed
41 enrolled
Breast

Breast Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡